Viewing Study NCT05043402


Ignite Creation Date: 2025-12-25 @ 3:44 AM
Ignite Modification Date: 2026-02-21 @ 6:36 PM
Study NCT ID: NCT05043402
Status: UNKNOWN
Last Update Posted: 2022-08-15
First Post: 2021-09-07
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of Navicixizumab in Patients With Platinum Resistant Ovarian Cancer
Sponsor: OncXerna Theraputics, Inc.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Ovarian Cancer View
None Fallopian Tube Cancer View
None Primary Peritoneal Carcinoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Platinum-Resistant View